RVx 2001
Alternative Names: RVx-2001Latest Information Update: 09 Mar 2022
At a glance
- Originator Southern Illinois University School of Medicine; University of Kansas
- Developer Rational Vaccines
- Class Attenuated vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Herpes simplex virus type 2 infections
Most Recent Events
- 19 Jan 2022 Preclinical trials in Herpes simplex virus type 2 infections (Prevention) in USA (Rational Vaccines pipeline, January 2022)
- 19 Jan 2022 Rational Vaccines plans a clinical trial for Herpes simplex virus type 2 infections (Rational Vaccines pipeline, January 2022)
- 19 Aug 2015 Herpes simplex virus mutant Infected Cell Protein licensed to Rational Vaccines by May 2015